hengrui glp-1 glp 1 BMS signs $15.2bn R&D alliance with China's Hengrui BioCentury - Hengrui and Kailera's

Each of the reaction mixtures were terminated by the addition of 250 l of ethyl acetate, extracted with 1 ml of methyl tert-butyl ether

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised phase 2 trial

These cardiovascular benefits are particularly important because obesity is a major risk factor for heart disease, stroke, and related conditions

By addressing both diabetes and obesity, GLP-1 medications have become a valuable tool for improving overall health and well-being

It provides a targeted approach to glucose management without causing low blood sugar on its own